 | |
- close
- close
|
Business Wire
Nov 25
Comment
Enzo Biochem, Inc. (NYSE:ENZ) announced today that its Board of Directors approved the termination of Shahram K. Rabbani’s services as the Company’s Secretary and Treasurer, respectively, effective immediately. At this time, Mr. Rabbani will
Business Wire
Nov 18
Comment
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with GeneNews (TSX: GEN), of Toronto, Canada, for exclusive rights to market GeneNews’ ColonSentry™, a proprietary blood test for colorectal cancer, in the states
Business Wire
Nov 4
Comment
Enzo Biochem, Inc. (NYSE:ENZ) today reported on the Company’s therapeutic platforms utilizing oral immune regulation for immune mediated diseases at the Bio-Europe 2009 15th Annual International Conference here calling it a “bright area of
Business Wire
Oct 15
Comment
Enzo Biochem, Inc. (NYSE:ENZ) today said that its Life Sciences subsidiary will release a new catalog dealing with “Epigenetics & Chromatin Modification” at the Society for Neuroscience’s, Neuroscience 2009 conference, beginning October 17,
StreetInsider.com
Oct 14
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Enzo+Biochem+%28ENZ%29+Reports+Q4+Loss+of+%240.14%2C+Misses+by+6c/5017628.html for the full story.
Business Wire
Oct 14
Comment
Enzo Biochem, Inc. (NYSE:ENZ) today reported a 16% increase in total operating revenue, to $24.5 million, and a 19% increase in gross profit, to $10.6 million, for the fourth fiscal quarter ended July 31, over the comparable quarter last year. The
Business Wire
Oct 13
Comment
Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss its fiscal 2009 fourth quarter results on Thursday, October 15, 2009, at 8:30 AM ET. To listen to the conference call dial 1-888-459-5609. International callers can dial
Business Wire
Oct 7
Comment
Enzo Biochem, Inc.’s (NYSE:ENZ) Enzo Life Sciences division today announced the addition of a new apoptosis detection kit for monitoring chromatin condensation to its rapidly expanding CELLestial™ product line for live cell analysis. Enzo
Business Wire
Oct 1
Comment
Enzo Biochem, Inc. (NYSE:ENZ) announced today a co-marketing partnership between its Enzo Life Sciences subsidiary, a world leader in non-radioactive probe technology, and BioTek Instruments, a privately held global leader in the development,
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ENZ AT A GLANCE
References
| ||||||
|
|
